RESEARCH: CANCER
FOLDING PROJECT #16923 PROFILE

This project relates to understanding how tiny protein building blocks called hairpins fold into shapes. By changing things like chemical links and the code that makes up these proteins, scientists can learn how to design better 'affibody' drugs that target cancer cells.

Note: This TLDR is a simplication and may not be 100% accurate.

These simulations are designed to test our understanding the folding mechanism of alpha-helical hairpins.

We are trying to study how disulfide cross-linkers and sequence variants affect the folding thermodynamics and kinetics of these proteins, to learn how we might better use molecular simulation methods to design effective protein binder scaffolds, for use as "affibody" cancer therapeutics, for example.

---

alpha-helical hairpins

A secondary structure in proteins characterized by a helix shape.

Alpha-helical hairpins are a type of protein structure where the protein chain forms a helical shape. This helix then folds back on itself, creating a hairpin-like structure. These structures are important for many biological processes.

---

disulfide cross-linkers

Covalent bonds formed between two cysteine amino acids in a protein.

Disulfide cross-linkers are strong chemical bonds that can form between two sulfur atoms within a protein. They help to stabilize the protein's structure and shape, making it more resistant to changes.

---

sequence variants

Alterations in the order of nucleotides within a gene.

Sequence variants are changes in the DNA code that make up a gene. These changes can lead to variations in the protein produced by the gene, which can have an impact on biological function.

---

molecular simulation methods

Techniques used to model the behavior of molecules and their interactions using computers.

Molecular simulation methods use computer programs to mimic the behavior of molecules. This allows scientists to study how molecules interact with each other and their environment, which can be helpful for drug discovery and development.

---

protein binder scaffolds

Structural frameworks designed to bind to specific target proteins.

Protein binder scaffolds are like the basic building blocks for creating molecules that can specifically bind to other proteins. This has applications in drug development, where these scaffolds can be used to create drugs that target specific proteins involved in disease.

---

affibody

A genetically engineered protein that binds to specific targets with high affinity.

Affibody is a type of small protein engineered to bind tightly to specific molecules. They are like smaller, more stable versions of antibodies and have potential use in diagnostics and therapy.

---

cancer therapeutics

Medical treatments used to treat cancer.

Cancer therapeutics are any medications or therapies designed to treat cancer. This can include chemotherapy drugs, radiation therapy, and targeted therapies that aim to specifically attack cancer cells.